CNBC
cnbc.com
did:plc:m7ks2xhfuku7errrtfjux2lg
Direct-to-consumer sales for obesity drugs are about to boom. JPMorgan sees Eli Lilly as big winner https://cnb.cx/4kS2oH3
2026-02-25T15:47:08.355Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.